Santibáñez-Morales Á, Durán-Boullosa E, Colín-Licea EO

Language: Spanish
References: 7
Page: 567-572
PDF size: 318.35 Kb.

ABSTRACT

Background: Ovarian stimulation is the cornerstone in fertility treatments, it produces multifolicular development and in consequence, a greater pregnancy rate. Poor responder patients have bad outcomes in IVF, several medical approaches have been proposed in managing these patients, including Growth Hormone.
Objetive: To report our results with the use of growth hormone and review published data.
Materials and Methods: Case series conducted from January 2013 to May 2015 in patients to Centro de Reproducción PROCREA, Mexico City, poor responders according to the criteria of consensus Bologna cycles in fresh stimulation protocol Flare up, application of growth hormone as adjuvant, complete cycles of stimulation (stimulation, oocyte capture, and embryo transfer pregnancy test) and complete records. For statistical analysis, averages and percentages were used.
Results: 40 cases were analyzed. Age and BMI were 39.1 ± 2.1 years and 24.6 ± 2.8 kg/m², respectively. Total gonadotrophin dose was 2128.6 ± 1078.9 UI, retrieved oocytes and fertilized eggs were 7.1 ± 4.0 y 5.4 ± 2.8 respectively. Fertilization rate was 76.3% and pregnancy rate was 59.5%.
Conclusion: There is insufficient evidence for prescribing GH in all patients requiring IVF, nevertheless, in poor responder patients, there seems to be an improvement in egg quality leading to better fertilization and pregnancy rate, with no adverse effects.

REFERENCES

1. Polyzos N, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertility and Sterility. 2011; 96(5):1058-1068.

2. Haadsma M, Groen H, Mooij TM, Burger C, Broekmans F, Lambalk C, et al. Miscarriage risk for IVF pregnancies in por responders to ovarian hyperstimulation. Reproductive Biomedicine Online 2010;20:191-200.

3. Ferraretti A.P., La Marca A, Fauser B.C.J.M., Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of “poor response” to ovarian stimulation for in vitro fertilization: the Bologna criteria. Human Reproduction 2011;26(7):1616-1624.

4. Duffy J, Ahmad G, Mohitiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane database of systematic reviews 2010, I.

5. de Ziegler D, Struli I, Meldrum D, Chapron C. The value of growth hormone supplements in ART for poor ovarian responders. Fertility and Sterility. 2011; 96(5): 1069: 1076.

6. Pandian Z, McTavish AR, Aucott L, Hamilton MPR, Bhattacharya S. Interventions for poor responders to controlled ovarian hyper stimulation (COH) in in-vitro fertilization (IVF). Cochrane Database of Systematic Reviews 2010, Issue 1. Art. No. CD004379.DOI:10.1002/14651858. CD004379.pub3.

7. Schoolcraft W, Schenker T, Gee M, Wagley L. Improved controlled ovarian hyperstimulation in poor responder in vitro fertilization patients with a micro dose folliclestimulating hormone flare, growth hormone protocol. Fertil Steril 1997;67(1):93-97.